SA

Sajil Ahmed

Active Director Director DIN 05202203
DIN 05202203 First appointment Mar 2012 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2012
Shareholding value •••• Premium profile

About Sajil Ahmed

Data last updated:

Sajil Ahmed is a Director at Ngs Biotech Private Limited (since 2012). The company operates in Life Sciences. Ngs Biotech Private Limited reported revenue of ₹39.6 Lakh (FY 2024).

DIN 05202203
Primary Designation Director
Industry Life Sciences
First Appointment 06 Mar 2012
Oldest Company Age 14 yrs
Largest company Ngs Biotech Private Limited · ₹39.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ngs Biotech Private Limited U85100DL2012PTC232493
Director06 Mar 20122012₹39.6 Lakh (FY 2024)Active

Board colleagues of Sajil Ahmed

NameDINCompanyDesignation
Tauqueer Ahmad05202130Ngs Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ngs Biotech Private Limited
Premium access

Shareholding and investment profile for Sajil Ahmed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sajil Ahmed

Sajil Ahmed currently holds 1 directorship: Ngs Biotech Private Limited (Director, since 06 Mar 2012, revenue ₹39.6 Lakh (FY 2024)).

Sajil Ahmed was first appointed on 06 Mar 2012 as Director at Ngs Biotech Private Limited.

The current boards of Sajil Ahmed's companies include Tauqueer Ahmad (Ngs Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available